White Paper

Upstream Viral Safety: A Holistic Approach To Mitigating Contamination Risks

Risk Decision

The safety of biologics from adventitious agents relies on a multilayered strategy that encompasses controlled manufacturing processes and the biomanufacturers’ implementation of risk mitigation strategies to prevent contamination. This holistic approach has delivered safe products for human use for many decades and continues to meet today’s expanding patient needs.

This whitepaper describes how different elements of viral safety can be integrated to minimize the risk of bioreactor contamination and the resulting disruption to biomanufacturing operations.

VIEW THE WHITE PAPER!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online